Interestingly, one tumor with a germline BRCA2 variant also harbored a low allele frequency of somatic BRCA2 mutation in addition to LOH, suggesting clonal heterogeneity in the tumor over time, with independent events leading to biallelic inactivation. Here, BRCA2 is linked to neoplasm.